By Fahim Awan
12:57 AM UTC
At last check-in after-hours trading, shares of Creative Medical Technology Holdings Inc. (CELZ) were up 12.18% at $1.75. Creative Medical Technology (CELZ) stock closed the last session at $1.56, decreasing -8.77% or -$0.15. Shares of the company fluctuated between $1.56 and $2.06 throughout the day. The number of shares exchanged was 1.39 million, greater than the company’s 50-day daily volume of 1.27 million and lower than its Year to date volume of 2.67 million.
In the past 12 months, Creative Medical Technology (CELZ) stock has advanced -92.35%, and in the last week, the stock has moved down -0.64%. For the last six months, the stock has lost a total of -83.49%, and over the last three months, the stock has decreased by -28.44%. CELZ stock jumped in extended trades after presenting in a significant event.
Creative Medical Technology (CELZ) is a business stage biotechnology organization that works in foundational microorganism innovation in the fields of immunotherapy, urology, nervous system science, and muscular health.
Creative Medical Technology (CELZ) reported that its chiefs partaken in the 34th Annual Roth Conference held March 13-15, 2022 in Dana Point, California. CELZ Management was accessible for one-on-one gatherings all through the meeting.
Creative Medical Technology (CELZ) as of late designated Sahil Nock as the Company’s Chief Commercial Officer, powerful February 28, 2022. Mr. Nock brings to CELZ over 15 years of medical care administration experience in deals, promoting, and business advancement. He generally as of late filled in as Head of US Commercial Marketing at Mentor, the overall innovator in bosom feel and a Johnson and Johnson Medical Device Company.